Related Experiment Video

Updated: Jun 20, 2026

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
11:50

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit

Published on: January 7, 2020

[Treatment of premature infant is changing]

Liisa Lehtonen1

  • 1TYKS:n lastenklinikka, Kiinamyllynkatu 4-8, 20520 Turku.

Duodecim; Laaketieteellinen Aikakauskirja
|August 29, 2009
PubMed

Insights

Neonatal research advances evidence-based medicine, focusing on brain protection for premature infants. This approach improves developmental outcomes and emphasizes family-centered care, with regionalization reducing mortality.

Area of Science:

  • Neonatology
  • Evidence-based medicine
  • Developmental neuroscience

Context:

  • Neonatology is evolving into an evidence-based medical field.
  • Increasing research supports patient-friendly and family-centered care models.
  • Optimizing brain protection is crucial for premature infant development.

Purpose:

  • To improve the developmental prognosis of premature infants through enhanced brain protection strategies.
  • To underscore the importance of developmental follow-up for premature infants.
  • To highlight the impact of regionalizing very premature deliveries in university hospitals on mortality rates.

Summary:

  • Active research in neonatology is driving an evidence-based approach.
  • Therapeutic strategies focus on optimizing brain protection to improve developmental outcomes.
  • Family-centered care and developmental follow-up are key components of modern neonatology.
  • Regionalizing very premature births to specialized university hospitals is shown to decrease mortality.

Impact:

  • Improved developmental prognosis for premature infants.
  • Enhanced patient and family-centered care in neonatal units.
  • Reduced mortality rates for very premature infants through specialized care delivery.

More Related Videos

Preterm EEG: A Multimodal Neurophysiological Protocol19:32

Preterm EEG: A Multimodal Neurophysiological Protocol

Published on: February 18, 2012

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: